Heartland Food Products Group makes key breakthrough in sucralose manufacturing technology

NewsGuard 100/100 Score

Heartland Food Products Group, one of world's leading producers and marketers of zero calorie sweeteners and liquid water enhancers for consumer markets and its sister corporation Lexington Pharmaceuticals announce a breakthrough in sucralose manufacturing technology.  Sucralose is the high intensity sweetener frequently sold in the tabletop market in yellow packets. Lexington is in final phase to receive patents from the United States Patent and Trademark Office and is working with process engineers to design a plant dedicated to this new technology.

Heartland is also currently engaged in a search for partners in this manufacturing venture focused on favorable sites in both the U.S. and Asia. 

Current sucralose manufacturing, even by the most advanced manufacturers, requires temperatures which force degradation of the material and do not allow for any recycling of the large amount of unusable reaction mixture.  The new technology does not require high temperature and allows robust recycling of any unused intermediate material and further recycling of the other reaction compounds-increasing reported yields by up to 40% with the same amount of component input. 

"We have invested heavily in this research over the past 10 years.  We have perfected the technology and are ready for commercialization," said Ted Gelov CEO of Heartland Food Products Group.  "Sucralose is made from sugar and with this process the usable conversion of sugar to sucralose is increased significantly," stated W. Randal Erickson, PhD Lexington Pharmaceuticals.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Food additive emulsifiers linked to increased risk of type 2 diabetes